Literature DB >> 20967621

RNA and DNA microarrays.

Stuart C Sealfon1, Tearina T Chu.   

Abstract

The development of microarray technology has revolutionized RNA and deoxyribonucleic acid (DNA) research. In contrast with traditional biological assays, microarrays allow the simultaneous measurement of tens of thousands of messenger RNA (mRNA) transcripts for gene expression or of genomic DNA fragments for copy number variation analysis. Over the past decade, genome-wide RNA or DNA microarray analysis has become an essential component of biology and biomedical research. The successful use of microarrays requires attention to unique issues of experimental design and execution. This chapter provides an overview of the methodology and applications of RNA and DNA microarrays in various areas of biological research.

Mesh:

Substances:

Year:  2011        PMID: 20967621     DOI: 10.1007/978-1-59745-551-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer

Authors:  Cheng-Cao Sun; Shu-Jun Li; Wei Hu; Jian Zhang; Qun Zhou; Cong Liu; Lin-Lin Li; Yi-Yan Songyang; Feng Zhang; Zhen-Long Chen; Guang Li; Zhuo-Yue Bi; Yong-Yi Bi; Feng-Yun Gong; Tao Bo; Zhan-Peng Yuan; Wei-Dong Hu; Bo-Tao Zhan; Qian Zhang; Qi-Qiang He; De-Jia Li
Journal:  Mol Ther       Date:  2019-04-06       Impact factor: 11.454

2.  Collagenase-based Single Cell Isolation of Primary Murine Brain Endothelial Cells Using Flow Cytometry.

Authors:  Cathrin J Czupalla; Hanadie Yousef; Tony Wyss-Coray; Eugene C Butcher
Journal:  Bio Protoc       Date:  2018-11-20

3.  RNA Extraction from a Mycobacterium under Ultrahigh Electric Field Intensity in a Microfluidic Device.

Authors:  Sai Ma; Bryan D Bryson; Chen Sun; Sarah M Fortune; Chang Lu
Journal:  Anal Chem       Date:  2016-04-27       Impact factor: 6.986

4.  The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.

Authors:  Hua-Tao Wu; Jing Liu; Guan-Wu Li; Jia-Xin Shen; Yi-Teng Huang
Journal:  Oncotarget       Date:  2017-05-30

5.  Expression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia.

Authors:  Cheng-Cao Sun; Shu-Jun Li; Zhen-Long Chen; Guang Li; Qian Zhang; De-Jia Li
Journal:  Mol Ther Oncolytics       Date:  2018-12-18       Impact factor: 7.200

6.  Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients.

Authors:  Yanjie You; Yuhong Ma; Qiang Wang; Zhengcai Ye; Yanhong Deng; Feihu Bai
Journal:  Cancer Manag Res       Date:  2019-02-05       Impact factor: 3.989

7.  Association between chromosomal aberration of COX8C and tethered spinal cord syndrome: array-based comparative genomic hybridization analysis.

Authors:  Qiu-Jiong Zhao; Shao-Cong Bai; Cheng Cheng; Ben-Zhang Tao; Le-Kai Wang; Shuang Liang; Ling Yin; Xing-Yi Hang; Ai-Jia Shang
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

8.  Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.

Authors:  Cheng-Cao Sun; Qun Zhou; Wei Hu; Shu-Jun Li; Feng Zhang; Zhen-Long Chen; Guang Li; Zhuo-Yue Bi; Yong-Yi Bi; Feng-Yun Gong; Tao Bo; Zhan-Peng Yuan; Wei-Dong Hu; Bo-Tao Zhan; Qian Zhang; Qi-Zhu Tang; De-Jia Li
Journal:  Aging (Albany NY)       Date:  2018-05-11       Impact factor: 5.682

9.  Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.

Authors:  Lin Cheng; Zhangmin Tan; Zenan Huang; Yuhang Pan; Wenhui Zhang; Jiani Wang
Journal:  Med Sci Monit       Date:  2020-08-24

Review 10.  Expressions and prognostic values of the E2F transcription factors in human breast carcinoma.

Authors:  Ze-Long Liu; Xi-Wen Bi; Pan-Pan Liu; De-Xin Lei; Yu Wang; Zhi-Ming Li; Wen-Qi Jiang; Yi Xia
Journal:  Cancer Manag Res       Date:  2018-09-13       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.